cdn mobile

Cebu receives additional 50k doses of Pfizer vaccines

By: Morexette Marie B. Erram - CDN Digital Multi-Media Reporter | August 26,2021 - 04:41 PM

Pfizer-BioNTech COVID-19 vaccines

| File photo

CEBU CITY, Philippines —  Cebu received an additional supply of Pfizer-BioNTech COVID-19 vaccines.

Dr. Mary Jean Loreche, the spokesperson of the Visayas Vaccination Operations Center (VVOC), confirmed to reporters that 50,310 doses of the mRNA vaccines arrived at Mactan-Cebu International Airport on Wednesday evening, August 25.

The shipment formed part of the 362,700 doses the Philippines procured from the US pharmaceutical giant, said Loreche.

Loreche, however, said they are yet to announce the allocation of the newly arrived vaccines.

Central Visayas, where Cebu belongs, has already received a total of 2,792,100 doses of the COVID-19 vaccines, including the new batch of Pfizer-BioNTech. /rcg

RELATED STORIES

More supply of Pfizer-BioNTech vaccines arrive in Cebu

Over 5K gets inoculated with Pfizer this week in Cebu City

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: Central Visayas, COVID-19 vaccines, Dr. Mary Jean Loreche, Mactan Cebu International Airport, Pfizer-BioNTech, VVOC
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.